Study reveals that aspirin helps the body’s immune system detect and target cancer cells.
Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson’s progression
A recent study in Nature Medicine evaluated the efficacy of prasinezumab, a monoclonal antibody, in slowing the progression of motor symptoms in Parkinson’s disease patients